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Abstract
Purpose: To evaluate factors affecting psychology, cognitive function and quality of life (QOL) of nasopharyngeal carcinoma
(NPC) patients with radiation-induced brain injury (RI).
Methods and Materials: 46 recurrence-free NPC patients with RI and 46 matched control patients without RI were recruited
in our study. Subjective and objective symptoms of RI were evaluated with the LENT/SOMA systems. Psychological
assessment was measured with Self-Rating Anxiety Scale (SAS) and Self-Rating Depression Scale (SDS). Montreal Cognitive
Assessment (MoCA) was carried out in these patients for assessing their cognitive function. QOL was evaluated by means of
WHOQOL BREF.
Results: Of the patients with RI, 39(84.8%) had depression and 40(87.0%) had anxiety. The patients with RI got higher scores
both in SDS and SAS than those without RI (SDS, 63.4868.11vs. 58.6767.52, p=0.008; SAS, 67.36610.41vs. 60.3469.76,
p=0.005). Score in MoCA of patients with RI was significantly lower than that of patients without RI (21.3262.45vs.
25.9861.73, p,0.001). SAS was positive correlated with post-radiotherapy interval. Both SAS and SDS had a significantly
positive correlation with the rank of SOMA, while MoCA had a significantly negative correlation with SOMA. Chemotherapy
was a risk factor for cognitive dysfunction. In addition, patients with RI got significantly lower scores in physical health
(16.50611.05 vs. 35.02610.43, p,0.001), psychological health (17.70610.33 vs. 39.48612.00, p,0.001) and social
relationship (48.00618.65 vs. 67.15619.70, p,0.001) compared with those in patients without RI. Multiple linear regression
analysis revealed that anxiety and cognitive impairment were significant predictors of global QOL.
Conclusions: NPC patients with RI exhibit negative emotions, impaired cognitive function and QOL. The severity of clinical
symptoms of RI plays an important role in both emotions and cognitive function. Anxiety and cognitive impairment are
associated with decreased QOL.
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Introduction
Nasopharyngeal carcinoma (NPC) is known as the high
incidence cancer in China [1], especially in Guangdong Province.
Radiotherapy (RT) is a long-standing mainstay of NPC treatment.
The cancer-specific survival rate of NPC is generally favorable,
and thus long term side effects of treatment are of concern in
survivors. Among the large range of complications encountered,
radiation-induced brain injury (RI) is a severe complication.
Compared with patients who had tumors in other head and
neck regions, patients with NPC had much worse impairment in
social and role function [2,3]. Although there have been some
reports [4,5]about psychological disorders, cognitive dysfunction
and QOL of NPC patients following RT, most of them focused on
the effects of therapies and with a relatively limited post-
radiotherapy interval. The psychological disorders and QOL of
patients with a long post- RT interval, especially of patients with
RI are seldom addressed. Comparison of psychological disorders
and QOL between patients with and without RI is not fully
elucidative. Whether psychological disorders are the complications
of RI or just frequently observed in patients following RT is still
poorly known. For these reasons, we undertook a psychological
study (including SAS and SDS), cognitive (MoCA) and QOL
(WHOQOL BREF) assessment in NPC patients with RI. The
results were compared with those of a matching post-radiotherapy
(post-RT) NPC patients without RI.
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This project was approved by an authorized human research
review board in our institute (Ethics Committee of The Sun Yat-
sen University). Patients included in this study were inpatients and
outpatients of the Sun Yat-sen Memorial Hospital of Sun Yat-sen
University and the Cancer Center of Sun Yat-sen University.
Written informed consents were obtained from all involved
subjects.
Patients
Between February 2009 and March 2010, patients who fulfilled
the following eligibility criteria were recruited as case group: (1) a
history of NPC with RT; (2)the clinical manifestation and the
magnetic resonance imaging (MRI) (Figure 1) or computed
tomography (CT) scan met the diagnosis of RI in Merritt’s
Neurology(10
th edition). All patients had clinical symptoms of RI.
(3) no evidence of symptomatic recurrent tumor, brain metastasis,
brain abscess, any intracranial tumor, cerebral infarction, demy-
elinating disease, encephalitis or other central nervous system
diseases; (4) no evidence of disturbance of consciousness or
unstable vital signs. There were 46 patients matching the criteria
including 35 males and 11 females.
The same amount of subjects was recruited within the same
period as control group. The subjects were matched for age,
gender, educational level, treatment modalities, and post-RT
interval. They also followed the criteria mentioned above except
the second one.
Methods to collect the historical information
The following data were retrieved from the clinical notes: (1)
age, gender, education background, occupation, marriage, resi-
dence area, medical information (date of starting RT, dosage, the
target volume, the duration time, with or without chemotherapy,
whether suffering from another central nervous system diseases);
(2) physical examination findings; (3) auxiliary examinations
including brain CT or MRI scan; (4) radiation toxicities scores
assessed by the Late Effects of Normal Tissue (LENT) –
Subjective, Objective, Management, Analytic (SOMA) Scales [6]
in patients with RI.
Figure 1. The brain MRI scan of a patient with RI. (A) The axial T1-weighted imaging showed relatively low-signal-intensity lesions in the
bilateral temporal lobes. (B) The T2-weighted imaging revealed high-signal-intensity lesions in the bilateral temporal lobes. T1-weighted image after
contrast administration (C) showed irregular edge contrast enhancement of the bilateral temporal lobes.
doi:10.1371/journal.pone.0036529.g001
Table 1. Characteristics of the two groups.
Characteristics Number of patients (%)
Case group
(n=46)
Control group
(n=46)
Gender
men 35(76.1) 35(76.1)
women 11(23.9) 11(23.9)
P.0.05
Age(ys)
Mean 6 SD 39.8615.1 39.6614.6
p.0.05
Educational level
illiteracy 2(4.3) 2(4.3)
Primary school 9(19.6) 9(19.6)
Junior high school 17(37.0) 16(34.8)
Technical secondary school
Or Senior high school
15(32.6) 17(37.0)
Undergraduate course 3(6.5) 2(4.4)
Postgraduate above 0 0
p.0.05
Residential place
City 20(43.5) 19(41.3)
Small town 19(41.3) 19(41.3)
Countryside 7(15.2) 8(17.4)
p.0.05
Post-RT(ys) 6.063.5 5.763.1
p.0.05
Chemotherapy 12(26.1) 12(26.1)
p.0.05
Abbreviation: SD = standard deviation.
doi:10.1371/journal.pone.0036529.t001
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Self-Rating Depression Scale (SDS): It is a 20-item self-reported
measurement of the symptoms of depression that includes
statements about cognitive, somatic, psychomotor, and affective
symptoms. Each item is scored from 1 to 4. Raw score is converted
into standardized score. A cut-off higher than 53 was used to
define presence of depression according to the Chinese version of
this scale [7].
Self-Rating Anxiety Scale (SAS): SAS is a 20-item scale, with some
of the items keyed positively and some negatively. They are
answered on a four-point scale ranging from 1(none or a little of
the time) to 4(most or all of the time). After being converted into
the standardized score, a cut-off 50 was used to define anxiety
according to the Chinese version of the scale [7].
Montreal Cognitive Assessment (MoCA): It assesses different cognitive
domains: attention and concentration, executive functions, mem-
ory, language, visuoconstructional skills, conceptual thinking,
calculations and orientation. Time to administer the MoCA is
approximately 10 minutes. The total possible score is 30, a score
of 26 or above is considered normal.
WHOQOL-BREF: The WHOQOL-BREF instrument compris-
es 26 items, which measure the following broad domains: physical
health, psychological health, social relationships, and environment
[8].
Statistical analysis
Paired-samples t test was used to compare the clinical
characteristics and the scores of SDS, SAS, MoCA and QOL
between the case group and control group. x2 test was performed
to compare the depression and anxiety scores between the two
groups. Stepwise multiple linear regression was applied to explore
predictors of psychological and cognitive disorders. Spearman’s
correlation was performed to examine the relationship between
SOMA and the scores of SDS, SAS, MoCA. All tests were two-
tailed and a 5% significance level was used for statistical
significance. The SPSS for windows, version 13.0 was used for
data processing.
Results
In case group, 46 patients were included in the analysis. The
median time after RT was 6.063.5 years (S.D.) (range from 1 to
19 years). The accumulated radiation doses were 68 to 76 Gy
(median, 70.2 Gy), with 2 Gy per fraction applied to the primary
tumor, and the estimated maximal dose to the adjacent brain was
70 Gy–73 Gy. All patients were treated with one fraction daily for
five days per week. Nineteen of them suffered from hypertension,
diabetes, chronic bronchitis and other medical morbidities.
Sixteen of them received chemotherapy (thirteen patients received
concurrent chemotherapy, three patients received both neoadju-
vant and concurrent chemotherapy). Forty-six matched controlled
post-RT patients without RI were recruited as control group. Two
major radiation fields, facial-cervical fields and facial-cervical split
fields were used in these patients. The demographic and other
background data for the two groups were similar (Table 1).
Psychopathology characteristics between the two
groups
In case group, 39(84.8%) patients had depression, 40(87.0%)
had anxiety, and 36 (78.3%) had both. In control group, 36
(78.3%) patients had depression, 38(82.6%) had anxiety. Table 2
shows that the overall incidence of depression and anxiety are not
significantly different between the two groups (84.8% vs. 78.3%,
P=0.420; 87.0% vs. 82.6%, P=0.562). But the standardized SDS
score and SAS score were much higher in the case group than
Table 2. Depression and Anxiety in Two Groups.
Case group
(n=46)
Control group
(n=46) P value
Morbidity of depression
Depression (%) 39(84.8) 36(78.3) 0.420
No depression (%) 7(15.2) 10(22.7)
SDS score 63.4868.11 58.6767.52 0.008
Morbidity of anxiety
Anxiety (%) 40(87.0) 38(82.6) 0.562
No anxiety (%) 6(13.0) 8(17.4)
SAS score 67.36610.41 60.3469.76 0.005
SDS score and SAS score are presented as mean 6 standard deviation.
Abbreviations: SDS = Self-rating Depression Scale; SAS = Self-rating Anxiety
Scale.
doi:10.1371/journal.pone.0036529.t002
Table 3. Multiple linear regression analysis of age, gender,
education, post-RT interval, and chemotherapy to SAS.
Model B-coefficient Std. Error P value Adj. R2
1 (constant) 59.834 2.239 ,0.001
Post-RT interval 0.687 0.334 0.043 0.034
Abbreviations: SAS = Self-rating Anxiety Scale. Post-RT interval = post-
radiotherapy interval; Adj. = adjusted; Std. = standard.
doi:10.1371/journal.pone.0036529.t003
Table 4. Excluded variables
b.
Model Beta In t P value
Partial
correlation
Collinearity
Statistics
Tolerance
1a g e 20.010
a 20.090 0.929 20.010 0.945
gender 0.34
a 0.323 0.748 0.034 0.963
chemotherapy 0.067
a 0.650 0.518 0.069 1.000
Education-
background
0.029
a 0.279 0.781 0.030 0.998
a Predictors in the Model: (constant), post-RT interval.
b Dependent Variable: SAS.
doi:10.1371/journal.pone.0036529.t004
Table 5. Multiple linear regression analysis of age, gender,
education, post-RT interval, and chemotherapy to MoCA.
Model B-coefficient Std. Error P value Adj. R2
1 (constant) 21.050 1.157 ,0.001
chemotherapy 1.575 0.673 0.022 0.047
Abbreviations: MoCA = Montreal Cognitive Assessment; Adj. = adjusted; Std.
= standard.
doi:10.1371/journal.pone.0036529.t005
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67.36610.41 vs. 60.3469.76, P=0.005).
According to the categorical fashion, the incidence of severe
depression in the case group was 15.2%(seven patients). In the
control group, none suffered from severe depression. The
percentage of patients with severe depression as defined by
standardized SDS, was significantly higher in the case group
compared with the control group (p=0.017).
In the case group, the number of patients with severe anxiety
was 25 (54.3%). While in the control group, the number of severe
anxiety was 9(19.6%). The percentage of patients with severe
anxiety was significantly higher in the case group (p=0.004).
Cognitive function in the two groups
The MoCA score of case group and control group was
(21.3262.45) and (25.9861.73) respectively. Patients without RI
tended to score higher than those with RI (p,0.001).
Determinants of SDS, SAS and MoCA
A series of stepwise linear regression analyses was performed.
Results showed that post-RT was the significant predictor of SAS.
SAS score was significantly positive correlated with post-RT
interval (p=0.043) (Table 3, Table 4). Besides, chemotherapy was
the significant predictor of MoCA (P=0.047) (Table 5, Table 6).
But, gender, education background, age, post-RT interval or
chemotherapy had no significant association with severity of SDS
(p.0.05).
LENT/SOMA scale was used to evaluate the severity of clinical
symptoms of RI. Correlation analysis demonstrated that SAS and
SDS were significantly positively correlated with SOMA (Spear-
man’s correlation coefficient =0.335, p=0.023; correlation
coefficient =0.299, p=0.044). Also, cognitive function was
significantly negatively correlated with SOMA (Spearman’s
correlation coefficient =20.472, p=0.001).
WHOQOL-BREF
The raw scores are transformed into standard scores in line with
the WHOOL-100 Instrument [9]. The higher the score, the better
QOL the patients felt. Comparison of QOL scores between two
groups presented in Figure 2. Patients in the case group got
Table 6. Excluded variables
b.
Model Beta In t P value
Partial
correlation
Collinearity
Statistics
Tolerance
1a g e 20.083
a 20.769 0.444 20.081 0.907
gender 0.135
a 1.319 0.191 0.138 0.993
Post-RT
interval
20.012
a 20.119 0.905 20.013 1.000
Education-
background
0.033
a 0.324 0.747 0.034 0.993
a Predictors in the Model: (Constant), chemotherapy.
b Dependent Variable: MOCA.
doi:10.1371/journal.pone.0036529.t006
Figure 2. QOL in two groups. The bars represented four domains of
QOL as mean score 6 standard deviation. Patients in case group got
significantly lower score in the physical health (p,0.001), psychological
health (p,0.001) and social relationship (p,0.001). There was no
significant difference in score of environment domain between two
groups (p=0.203). Abbreviations: QOL = quality of life.
doi:10.1371/journal.pone.0036529.g002
Table 7. Multiple linear regression analysis of age, gender,
education, post-RT interval, chemotherapy, SAS, SDS and
MoCA to predict QOL.
Model B-coefficient Std. Error P value Adj. R2
1 (constant) 26.532 29.663 0.826
MoCA 7.109 1.243 ,0.001 0.258
2 (constant) 52.892 40.911 0.199
MoCA 6.650 1.241 ,0.001
SAS 20.760 0.367 0.041 0.284
Abbreviations: SAS = Self-rating Anxiety Scale; SDS = Self-rating Depression
Scale; MoCA = Montreal Cognitive Assessment; QOL = quality of life; Adj. =
adjusted; Std. = standard.
doi:10.1371/journal.pone.0036529.t007
Table 8. Excluded variables
b.
Model Beta In t P value
Partial
correlation
Collinearity
Statistics
Tolerance
1 age 0.027
a 0.295 0.768 0.031 1.000
gender 20.109
a 21.198 0.234 20.126 0.987
Post-RT
interval
20.063
a 20.699 0.486 20.074 1.000
chemotherapy 20.050
a 20.534 0.595 20.057 0.943
Education-
background
20.077
a 20.856 0.394 20.090 1.000
SAS 20.186
a 22.069 0.041 20.214 0.968
SDS 20.098
a 21.064 0.290 20.112 0.954
2 age 0.016
b 0.177 0.860 0.019 0.996
gender 20.092
b 21.023 0.309 20.108 0.978
Post-RT
interval
20.026
b 20.280 0.781 20.030 0.955
chemotherapy 20.029
b 20.316 0.753 20.034 0.931
Education-
background
20.074
b 20.828 0.410 20.088 0.999
SDS 20.081
b 20.891 0.375 20.095 0.946
a Predictors in the Model: (Constant), MOCA.
b Predictors in the Model: (Constant), MOCA, SAS.
doi:10.1371/journal.pone.0036529.t008
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control group (16.50611.05 vs. 35.02610.43, p,0.001). The
mean score for psychological health of case group was
17.70610.33, while the score of control group was
39.48612.00, there was a significant difference between two
groups (p,0.001). Also in social relationship, the score in case
group and control group was 48.00618.65 and 67.15619.70
respectively, the difference is significant (p,0.001). Yet, in
environment domain, the score in two groups was similar
(47.39616.69 vs. 52.00617.74, p=0.203).
To identify the determinants of QOL, the demographic data
and scores of SAS/SDS/MoCA were entered into the regression
analysis. We found that SAS score (p=0.041) and MoCA score
(p,0.001) were both the significant predictors (Table 7, Table 8).
Discussion
This study investigates emotional status, cognitive function and
QOL of post-RT NPC patients complicated with RI. Data were
compared with those of post-RT NPC patients without RI.
According to SDS and SAS assessment, more than three fourths of
patients after RT had either depression or anxiety. Previous
studies suggested that psychological disorders such as depression
and anxiety were apparent as early as the start of RT, and might
remain throughout the treatment [10,11,12]. Lee [13] carried out
a prospective study of the impact of RT on the psychosocial
condition of NPC patients. The results indicated that the period
from diagnosis to 2-month post RT was a high-risk period
emotionally. After treatment, most patients showed resilience and
resumed their pretreatment level of functioning by the end of the
year. The post-RT interval in our study was 6.063.5 years in the
case group and 5.763.1 years in the control group, which
indicated that psychological problems lasted long after radiother-
apy. Yet, how these psychological disorders develop or how they
influence patients’ QOL when patients suffer from RI remains
unclear. In our study, depression and anxiety incidence in patients
with RI was similar to that of patients without RI. But according to
the SDS and SAS scores, depression and anxiety were more severe
in patients with RI than those in patients without RI. These
indicated that RI itself may aggravate the severity of depression or
anxiety. In regard to the factors influencing anxiety and
depression, we found that except for post-RT interval, age,
gender, education and chemotherapy had no significant correla-
tion with either anxiety or depression. The major difference
between the case group and control group were the clinical
complications caused by radiotherapy. LENT/SOMA, a tool to
evaluate the severity of brain complication, was proved to had
correlation with both SAS and SDS, which suggested that RI was
likely to aggravate the severity of psychological disorders. It is
reasonable that patients feel upset when they still have to confront
RI which is unexpected even unbearable after the difficult
experience of RT. Patients often pay close attention to their slight
changes of body, worry about the recurrence of tumors, and keep
on consulting doctor frequently. All these are typical behaviors of
anxiety.
MoCA assesses different cognitive domains: attention and
concentration, executive functions, memory, language, visuocon-
structional skills, conceptual thinking, calculations, and orienta-
tion. Previous study found that the late effects of RT on cognitive
function included three situations: transitory cognitive impairment
primarily affecting attention and recent memory, which usually
occurred within the first 6 months after cranial RT; mild or
moderate cognitive impairment and dementia with leukoenceph-
alopathy occurred in the late delayed period [14]. Compared to
dementia, mild to moderate cognitive dysfunction is much more
frequent in long-term survivors. In our study, the patients had
worse cognitive function than patients without RI. This result was
consistent with earlier studies [12,15,16]. From these studies, there
appeared to be a correlation between the severity of cognitive
deficits and severity of abnormalities of white matter or temporal
lobe radio-necrosis. As cognitive dysfunction may result from
multifactorial complex interactions, including preexisting cognitive
abnormalities, concomitant treatments (chemotherapy, antiepilep-
tic, psychotropic drugs), match case control study can avoid the
confounding factors. From our results, chemotherapy was
demonstrated to be predictor of cognitive dysfunction. The
combination of RT and chemotherapy increased the incidence
of dementia have been proved by early studies [17]. Through
match control, usage of chemotherapy was similar in the two
groups, therefore we thought that impaired cognitive function was
mostly due to RI. Damage to cerebral blood vessels based on the
radiosensitivity of endothelium, as well as vascular vulnerability to
RT lead to RI and some represent cognitive impairment.
In our study, the most common symptoms in patients with RI
included impaired cognition, bulbar palsy, headache, dizziness,
syncope. Bulbar palsy is often caused by injury to the brain stem or
the lower cranial nerves, and it may eventually develop dysphagia
[18,19], which significantly decrease patients’ quality of life.
Patients with NPC after radiotherapy often have radiation-
induced lesions in the temporal lobe and therefore manifest
significant impairment in memory, language, motor performance,
and executive function [20]. If the lesions aggravate, or
superimpose with while matter edema, the patient might have
headache, dizziness and severe cognitive impairmen [21] Besides,
unusual complications such as oscillopsia [22], vertigo [23] are also
reported in long-term NPC survivors. All the above symptoms
decrease quality of life in NPC patients inevitably. Our score of
QOL showed a significant difference between patients with RI and
patients without RI in the following domains: physical health,
psychological health and social relationships. These results support
our presumption. Regression analysis also revealed that anxiety
and cognitive impairment might explain their lower score of QOL.
It is similar to the other studies [4,24,25] that, emotional status,
including depression and anxiety, are likely to impair QOL.
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